Teplizumab in Type 1 Diabetes Mellitus: An Updated Review
Touch ENDOCRINOLOGY,
1. DiMeglio LA, Evans-Molina C, Oram RA. Type 1 diabetes. Lancet. 2018;391:2449–62.
1. DiMeglio LA, Evans-Molina C, Oram RA. Type 1 diabetes. Lancet. 2018;391:2449–62.
Teplizumab is a medication, recently approved in the United States, to delay the onset of stage 3 type 1 diabetes mellitus in…
Pankreas /RAJCREATIONZS, stock.adobe.com Mnchen Der Ausbruch der chronischen Stoffwechselerkrankung Diabetes Typ 1 knnte knftig…